FDA Approvals - FDA, FTC Act To Remove Fraudulent STD Products From The
FDA, FTC Act To Remove Fraudulent STD Products From The Market
The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) today announced a joint effort to remove products from the market that make unproven claims to treat, cure, and prevent sexually transmitted diseases (STDs). Among the products targeted in today's action are Medavir, Herpaflor, Viruxo, C-Cure, and Never An Outbreak. The agencies issued multiple letters to ...